Dr. Hall serves as the program director for the Dose Optimization and Outcomes Research (DOOR) progam. The DOOR program focuses on providing evidence to optimize the dosing and outcomes of medications for obese patients. Dr. Hall was selected as a National Institutes of Health Clinical Research Scholar in 2006. He was also the recipient of the 2008 Young Alumni Award from the St. Louis College of Pharmacy.
obesity, pharmacokinetics, antimicrobial, cancer, outcomes research